All healthcare and quality professionals are invited to submit an abstract containing a summary of original research in the categories listed below. International submissions are encouraged.
Please note that abstracts submitted or recently presented at other meetings are eligible for presentation at the 2026 Quality, Safety & Cancer Conference.
Key Dates
- Monday, March 9, 2026 at 11:59 PM CT—Submission DEADLINE (Revisions and late submissions will not be accepted after the deadline.)
- Mid-April 2026—Notifications of Acceptance
- Mid-May 2026—Confirm Acceptance via the Conference Portal
- July 30–August 2, 2026—Quality, Safety & Cancer Conference in Orlando, FL (in person)
Presenters are required to register themselves for the meeting. Registration will open in spring 2026. Due to the size and scope of the meeting, the ACS does not provide reimbursement for airfare, hotel honorarium, etc., to abstract presenters.
Presenters will be required to print and bring their poster onsite at their own expense.
We appreciate your willingness to share your research and contribute to the continuing education of surgeons in the field. We look forward to seeing you in Orlando!
We welcome submissions in the following categories:
|
|
|
We welcome submissions in the following categories:
|
|
|
At the Quality, Safety & Cancer Conference submitted abstracts may qualify for one or both types of presentations: podium and/or poster. There is no limit on the number of abstracts an author may submit. Acceptance decisions, including whether an abstract is selected for a podium or poster presentation, will be determined by the reviewing committee.
Please note: If a change in presenting author is needed after submission or acceptance, this is permitted. Please email acsqsconference@facs.org as soon as possible to update presenter information. The deadline to change the presenting author is July 6, 2026. No more changes will be accepted after the deadline.
Authors who use artificial intelligence (AI) tools in the writing of an abstract, production of images or graphical elements, or in the collection and analysis of data must disclose in the Materials and Methods (or similar section) of the abstract how the AI tool was used and which tool was used. Authors remain fully responsible for the content of their submission, including any portions produced with an AI tool, and are liable for any breach of publication ethics.
Reviewers will score abstracts according to a defined rubric. All authors are expected to adhere to the ACS Statement of Integrity.
No changes can be made to the title, author string, or abstract body and table/figures after March 9, 2026.
In accordance with Accreditation Council for Continuing Medical Education (ACCME) guidelines, all named authors must complete an ACS disclosure statement during the submission process to disclose all financial relationships with any commercial interest. Submitters may not complete disclosures on their co-authors’ behalf. All authors should log in to the submission platform to complete the disclosure statement prior to presenting at QSCC.